Literature DB >> 6273838

Characterization of sites for tyrosine phosphorylation in the transforming protein of Rous sarcoma virus (pp60v-src) and its normal cellular homologue (pp60c-src).

J E Smart, H Oppermann, A P Czernilofsky, A F Purchio, R L Erikson, J M Bishop.   

Abstract

The transforming protein of Rous sarcoma virus (pp60v-src) and its normal cellular homologue (pp60c-src) appear to be protein kinases that phosphorylate tyrosine in a variety of protein substrates. In addition, pp60v-src and pp60-c-src are themselves phosphorylated on serine and tyrosine. It is likely that these phosphorylations serve to regulate the function(s) of pp60v-src and pp60c-src. We have therefore characterized the sites of tyrosine phosphorylation in the two proteins. Tyrosine phosphorylation of pp60v-src in infected cells occurs mainly (if not entirely) at residue 419 in the deduced amino acid sequence of the protein. Surrounding this residue is the sequence Leu-Ile-Glu-Asp-Asn-Glu-Tyr(P)-Thr-Ala-Arg. This peptide is distinguished by the fact that three out of the four amino acids that precede the phosphorylated tyrosine are acidic in nature. These results define what may prove to be a widely used site for tyrosine phosphorylation in the regulation of cellular function. The same site was phosphorylated when partially purified pp60v-src was used in a phosphotransfer reaction in vitro. The results with pp60c-src were more complex. The site of tyrosine phosphorylation in vitro appeared to be the same as that found in pp60v-src. By contrast, phosphorylation of pp60c-src in vivo apparently occurred at a different, and currently unidentified, tyrosine residue. It is therefore possible that pp60v-src and pp60c-src respond differently to regulatory influences in the intact cell.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6273838      PMCID: PMC348967          DOI: 10.1073/pnas.78.10.6013

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  32 in total

1.  Uninfected vertebrate cells contain a protein that is closely related to the product of the avian sarcoma virus transforming gene (src).

Authors:  H Oppermann; A D Levinson; H E Varmus; L Levintow; J M Bishop
Journal:  Proc Natl Acad Sci U S A       Date:  1979-04       Impact factor: 11.205

2.  Identification of a transformation-specific antigen induced by an avian sarcoma virus.

Authors:  J S Brugge; R L Erikson
Journal:  Nature       Date:  1977-09-22       Impact factor: 49.962

3.  Identification of a polypeptide encoded by the avian sarcoma virus src gene.

Authors:  A F Purchio; E Erikson; J S Brugge; R L Erikson
Journal:  Proc Natl Acad Sci U S A       Date:  1978-03       Impact factor: 11.205

Review 4.  Phosphorylation-dephosphorylation of enzymes.

Authors:  E G Krebs; J A Beavo
Journal:  Annu Rev Biochem       Date:  1979       Impact factor: 23.643

5.  Three species of polyoma virus tumor antigens share common peptides probably near the amino termini of the proteins.

Authors:  J E Smart; Y Ito
Journal:  Cell       Date:  1978-12       Impact factor: 41.582

6.  Evidence that the transforming gene of avian sarcoma virus encodes a protein kinase associated with a phosphoprotein.

Authors:  A D Levinson; H Oppermann; L Levintow; H E Varmus; J M Bishop
Journal:  Cell       Date:  1978-10       Impact factor: 41.582

7.  Structural analysis of the avian sarcoma virus transforming protein: sites of phosphorylation.

Authors:  M S Collett; E Erikson; R L Erikson
Journal:  J Virol       Date:  1979-02       Impact factor: 5.103

8.  Characterization of a normal avian cell protein related to the avian sarcoma virus transforming gene product.

Authors:  M S Collett; J S Brugge; R L Erikson
Journal:  Cell       Date:  1978-12       Impact factor: 41.582

9.  Cellular information in the genome of recovered avian sarcoma virus directs the synthesis of transforming protein.

Authors:  R E Karess; W S Hayward; H Hanafusa
Journal:  Proc Natl Acad Sci U S A       Date:  1979-07       Impact factor: 11.205

10.  A mouse homolog to the avian sarcoma virus src protein is a member of a protein kinase cascade.

Authors:  M Spector; R B Pepinsky; V M Vogt; E Racker
Journal:  Cell       Date:  1981-07       Impact factor: 41.582

View more
  127 in total

1.  Putative tyrosine kinases expressed in K-562 human leukemia cells.

Authors:  J Partanen; T P Mäkelä; R Alitalo; H Lehväslaiho; K Alitalo
Journal:  Proc Natl Acad Sci U S A       Date:  1990-11       Impact factor: 11.205

2.  The catalytic activity of the Src family kinases is required to disrupt cadherin-dependent cell-cell contacts.

Authors:  D W Owens; G W McLean; A W Wyke; C Paraskeva; E K Parkinson; M C Frame; V G Brunton
Journal:  Mol Biol Cell       Date:  2000-01       Impact factor: 4.138

Review 3.  Taking STEPs forward to understand fragile X syndrome.

Authors:  Susan M Goebel-Goody; Paul J Lombroso
Journal:  Results Probl Cell Differ       Date:  2012

4.  Deciphering the cross talk between hnRNP K and c-Src: the c-Src activation domain in hnRNP K is distinct from a second interaction site.

Authors:  Dörte Adolph; Nadine Flach; Katharina Mueller; Dirk H Ostareck; Antje Ostareck-Lederer
Journal:  Mol Cell Biol       Date:  2006-12-18       Impact factor: 4.272

Review 5.  Src family kinases and the MEK/ERK pathway in the regulation of myeloid differentiation and myeloid leukemogenesis.

Authors:  Daniel E Johnson
Journal:  Adv Enzyme Regul       Date:  2007-11-19

6.  Blood platelets express high levels of the pp60c-src-specific tyrosine kinase activity.

Authors:  A Golden; S P Nemeth; J S Brugge
Journal:  Proc Natl Acad Sci U S A       Date:  1986-02       Impact factor: 11.205

7.  Inhibition of the tyrosine kinase activity of v-src, v-fgr, and v-yes gene products by a monoclonal antibody which binds both amino and carboxy peptide fragments of pp60v-src.

Authors:  D J McCarley; J T Parsons; D C Benjamin; S J Parsons
Journal:  J Virol       Date:  1987-06       Impact factor: 5.103

8.  Forms of pp60v-src isolated from Rous sarcoma virus-transformed cells.

Authors:  M S Collett; S K Belzer
Journal:  J Virol       Date:  1987-05       Impact factor: 5.103

9.  Structural basis for chromosome X-linked agammaglobulinemia: a tyrosine kinase disease.

Authors:  M Vihinen; D Vetrie; H S Maniar; H D Ochs; Q Zhu; I Vorechovský; A D Webster; L D Notarangelo; L Nilsson; J M Sowadski
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-20       Impact factor: 11.205

10.  Differential modulation of plasminogen activator gene expression by oncogene-encoded protein tyrosine kinases.

Authors:  S M Bell; D C Connolly; N J Maihle; J L Degen
Journal:  Mol Cell Biol       Date:  1993-09       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.